The 15 Largest Telehealth Companies in 2026

Research Digital Health
By Dr. Jason Lee in New York City
Last updated: September 30, 2026

The telehealth space has moved well beyond simple video consultations with a physician. Today it covers digital pharmacies, virtual-first primary and specialty care, chronic condition management, mental health services, physician practice management and associated software systems, and remote patient monitoring, among others. Many of these services are being delivered by hybrid healthcare companies where a substantial share of patient interactions are conducted remotely.

The field is also far broader than the pure-play telehealth companies shown here.

For this ranking, SANOR looked at publicly traded companies in the healthcare and digital health space. We include companies where telehealth is their core business or a significant operating platform for large patient or provider bases. Companies were ranked by total market capitalization as of 11th September 2026.

The Ranking at a Glance

Taken together, the 15 companies were worth $50.2 billion at the close on 11th September 2026. Their combined revenues from their latest fiscal years totaled $27.5 billion. Revenues for the three Chinese companies in the list together totaled 61% of that amount, and their combined market value totals 44% of the total market value of all 15 companies.

There is considerable variation in price to sales, ranging from a low of 0.4x for Teladoc Health to 12.2x for Hinge Health.

RankCompanyMarket cap (11th Sep 2026)Revenue (latest FY)Price-to-sales
1JD Health$14.1 billion$10.9 billion1.3x
2Hinge Health$7.15 billion$588 million12.2x
3Hims & Hers Health$6.42 billion$2.35 billion2.7x
4Alibaba Health$6.23 billion$5.1 billion1.2x
5LifeStance Health$4.96 billion$1.42 billion3.5x
6Doximity$4.56 billion$645 million7.1x
7Ping An Healthcare and Technology$1.69 billion$815 million2.1x
8Omada Health$1.20 billion$260 million4.6x
9GoodRx$1.16 billion$797 million1.5x
10Teladoc Health$1.12 billion$2.53 billion0.4x
11Terveystalo$1.11 billion$1.48 billion0.7x
12Amwell$221 million$249 million0.9x
13LifeMD$147 million$194 million0.8x
14Kooth$91 million$86 million1.1x
15DarioHealth$68 million$22 million3.0x
Total$50.2 billion$27.5 billion1.8x

Note that for those companies whose last fiscal year end is other than 31st December 2025 (Alibaba Health and Doximity), we have used the latest available fiscal year numbers. All non-U.S. dollar figures have been converted to USD at ECB reference rates as of 11th September 2026. Note also that the price-to-sales numbers have been calculated by SANOR from the figures above, using market capitalization divided by the latest available fiscal year’s revenue for each company.

1. JD Health (6618.HK)

JD Health is the online pharmaceutical and healthcare retail business of one of China’s largest retailers, combined with a large digital-care operation offering online consultations, specialty clinics, chronic-disease management and more.

Digital health is a key part of the business of JD Health. For the first 6 months of 2025, JD Health had an average of over 500,000 daily online consultations with its patients and provided digital and virtual health care services to patients with various diseases and conditions, including dermatological diseases, mental health and psychiatric conditions, oncology, and chronic diseases.

For FY2025, JD Health reported total revenue of RMB 73.4 billion (≈$10.9 billion), up 26.3% from FY2024, with 217.7 million active customers as of the end of 2025.

JD Health was trading with a market cap of HKD 110.8 billion (≈$14.1 billion) as of 11th September 2026.

2. Hinge Health (HNGE)

Hinge Health is a virtual-care company for the single clinical category of musculoskeletal care.

Hinge Health offers digital exercise therapy, clinicians and AI-assisted movement tracking and device technology to treat back and joint pain sufferers remotely.

Revenues for the company grew 50.6% to $587.9 million in FY2025 from $390.4 million the prior year. The company went public in May 2025 and, as of 11th September 2026, is the largest public company on this list focused on virtual care, with a market cap of $7.15 billion.

3. Hims & Hers Health (HIMS)

  • Headquarters: San Francisco, California
  • Primary Services: Direct-to-consumer virtual healthcare
  • Market Cap: $6.42 billion
  • Revenue: $2.35 billion (FY2025)
  • Telehealth Role: Core business

Hims & Hers is a direct-to-consumer virtual healthcare company that offers online medical consultations, writes prescriptions for necessary treatments, and provides patients with corresponding products and ongoing healthcare services across several consumer health categories.

The company services patients dealing with weight management, sexual health, hair loss, dermatology, hormone health and mental health.

For FY2025 the company reported $2.35 billion in revenue, representing a 59% year over year increase. Subscribers were up to over 2.5 million by the end of the period.

As of 11th September 2026, Hims & Hers had a market capitalization of $6.42 billion.

4. Alibaba Health Information Technology (0241.HK)

An example of how the digital health industry has evolved to the point where it is increasingly difficult to discuss telehealth in isolation from the wider digital health industry is Alibaba Health, a pharmaceutical retail and healthcare e-commerce business.

Pharmaceutical retail and healthcare e-commerce services are the mainstay of Alibaba Health’s top-line growth. In addition, the company operates a large digital medical-services business and has a network of nearly 270,000 physicians, pharmacists and nutritionists across the country who can deliver online health services within the Alibaba ecosystem.

Revenue for the year ended 31st March 2026 for Alibaba Health was RMB 34.3 billion (≈$5.1 billion), an increase of 12% over the prior year.

Its market capitalization stood at HKD 48.82 billion (≈$6.23 billion) on 11th September 2026.

5. LifeStance Health Group (LFST)

  • Headquarters: Scottsdale, Arizona
  • Primary Services: Outpatient mental healthcare
  • Market Cap: $4.96 billion
  • Revenue: $1.42 billion (FY2025)
  • Telehealth Role: Key delivery channel

LifeStance is a hybrid provider of mental health services, offering both in-person clinic and virtual care to patients. It operates 8,040 licensed clinicians in 33 states, according to data through year-end 2025.

LifeStance is currently one of the largest outpatient mental health networks in the country. In 2025, for example, the company treated over one million unique patients and conducted some nine million clinical visits.

Its market capitalization was $4.96 billion on 11th September 2026.

6. Doximity (DOCS)

Doximity is not a player in direct patient care, but rather a provider of infrastructure on top of the telehealth market.

Over 80% of U.S. physicians use Doximity’s professional network, and a suite of workflow tools allows doctors to hold secure voice and video calls with their patients.

Doximity reported $644.9 million in revenue for the company’s FY2026, representing a 13% increase year over year. In Q4 FY2026, over 800,000 active prescribers used the company’s workflow tools.

The company was valued at $4.56 billion as of the close on 11th September 2026.

7. Ping An Healthcare and Technology (1833.HK)

Ping An Healthcare and Technology offers online doctor consultations, hospital referrals and second opinions on its own platform.

Ping An Healthcare’s corporate health division serves over 6,700 paying corporations, and almost 12 million users are on the AI Doctor platform.

Ping An Healthcare’s market capitalization stood at HKD 13.24 billion (≈$1.69 billion) as of 11th September 2026.

8. Omada Health (OMDA)

  • Headquarters: South San Francisco, California
  • Primary Services: Virtual chronic-condition care
  • Market Cap: $1.20 billion
  • Revenue: $260.2 million (FY2025)
  • Telehealth Role: Core business

Omada Health delivers chronic condition management, including diabetes, hypertension, obesity, and musculoskeletal conditions, as well as behavioral health support via a virtual platform.

Its digital platform is augmented by health coaches as well as by clinicians, physical therapists and other members of a patient’s care team.

As of the end of 2025, the company had more than 2,000 customers and 886,000 enrolled members. Omada has also added support for patients taking GLP-1 medications.

Omada was valued at $1.20 billion on 11th September 2026.

9. GoodRx (GDRX)

  • Headquarters: Santa Monica, California
  • Primary Services: Prescription savings, pharmaceutical services and telehealth
  • Market Cap: $1.16 billion
  • Revenue: $796.9 million (FY2025)
  • Telehealth Role: Significant business within a broader consumer-health platform

GoodRx allows users to find the best price for their prescriptions and also offers GoodRx Care virtual care visits with contracted, physician-owned practices for pre-set prices, conducted by telephone or video.

In 2025, GoodRx generated $796.9 million in revenue.

While GoodRx has a telehealth business, the majority of its revenue (68% in 2025) comes from the traditional prescription transaction stream, making GoodRx more of a prescription savings and pharmacy services provider than a telehealth company. In practice, GoodRx operates as a consumer health marketplace.

GoodRx was trading as a $1.16 billion market cap company as of 11th September 2026.

10. Teladoc Health (TDOC)

  • Headquarters: New York, New York
  • Primary Services: Virtual primary care, chronic care and mental healthcare
  • Market Cap: $1.12 billion
  • Revenue: $2.53 billion (FY2025)
  • Telehealth Role: Core business

Teladoc, parent company of the online counseling platform BetterHelp, delivers primary and urgent care, chronic care management and mental health services, and connects patients with specialists.

While the company’s market capitalization is below that of several much younger and smaller companies, the operations of Teladoc are vastly larger.

The company generated $2.53 billion in revenue in FY2025 with over 17 million virtual visits, making it one of the largest pure-play virtual health companies by revenue and patient volume. Even so, Teladoc’s market capitalization of $1.12 billion sits below that of several smaller public healthcare companies, including a number that are less than 10 years old.

11. Terveystalo (TTALO.HE)

This Finnish health group is another example of a hybrid telehealth and brick-and-mortar provider.

Terveystalo has a large network of hospitals and clinics in Finland, but the company also delivered 1.19 million telehealth visits in 2025.

Currently there are some 2.7 million users on the group’s app, and they can have a telehealth visit 24/7.

Telehealth visits represent only a fraction of the group’s overall clinical service volume. The Healthcare Services business, which consists of the physical clinics, had 4.55 million patient visits in 2025.

In 2025, the company generated revenue of €1.279 billion (≈$1.48 billion) and has approximately 14,400 medical and other professionals.

Its market cap was $1.11 billion as of 11th September 2026.

12. American Well (Amwell) (AMWL)

  • Headquarters: Boston, Massachusetts
  • Primary Services: Enterprise virtual-care technology
  • Market Cap: $221 million
  • Revenue: $249.3 million (FY2025)
  • Telehealth Role: Core business

Amwell offers software, devices and infrastructure to the enterprise healthcare customer base of large healthcare organizations, health insurance companies, managed care organizations and government entities.

As of the end of 2025, approximately 50 health plans and 80 large health systems covering more than 90 million lives use Amwell technology at their organizations.

Since the company’s founding, Amwell technology has enabled virtual health care delivery to more than 37.6 million patients.

The company was valued at $221 million as of 11th September 2026.

13. LifeMD (LFMD)

LifeMD is a telehealth company that provides virtual care services directly to consumers for weight management as well as men’s and women’s health care services and primary care for individuals dealing with chronic lifestyle-related diseases.

As of 30th June 2026, the number of subscribers for the company’s services had increased to approximately 356,000 active subscribers, up from about 328,000 at the end of 2025.

LifeMD has served over 1.55 million patients since the company’s launch.

As of 11th September 2026, LifeMD had a market capitalization of $147 million.

14. Kooth (KOO.L)

Kooth is a London-based company that provides online mental health support to children, young people and adults in the UK and US. The company generates the bulk of its revenue from government contracts, large healthcare provider organizations and other institutional customers.

In 2025, Kooth’s revenue decreased by £3.4 million to £63.3 million (≈$86 million), from £66.7 million (≈$90 million) in 2024.

Market cap for Kooth on 11th September 2026 was $91 million.

15. DarioHealth (DRIO)

  • Headquarters: Caesarea, Israel
  • Primary Services: Virtual chronic-condition management
  • Market Cap: $68 million
  • Revenue: $22.36 million (FY2025)
  • Telehealth Role: Core business

Dario’s digital chronic care programs include programs for diabetes, hypertension, obesity and other musculoskeletal and behavioral health conditions.

Dario’s telehealth programs include connected devices, technology, data, analytics, coaching and virtual clinicians.

The company’s revenues declined to $22.36 million in FY2025 from $27.04 million in FY2024. Of the total revenues for the year, approximately $14.9 million were derived from services rendered.

Market cap was $68 million as of 11th September 2026.

What the Ranking Tells Us About the Telehealth Market

Telehealth is becoming a delivery model, not a standalone sector

The largest companies in the ranking are not one-dimensional.

JD Health combines telehealth services with online pharmacy retail, while Alibaba Health combines telehealth services with Alibaba’s e-commerce healthcare services.

LifeStance and Terveystalo offer physical clinics but combine traditional medicine with online delivery of services.

Doximity’s telehealth platform enables doctors to communicate with their patients remotely.

The companies listed above are not all just telehealth technology companies. As telehealth becomes an additional channel for services offered within many different business models, the companies listed here provide evidence of this evolution.

China has some of the world’s largest digital-care platforms

The ranking includes several leading Chinese companies in the telehealth space.

JD Health is the largest company in the ranking; in addition to running one of China’s largest online consultation platforms, the company also runs a large online pharmacy business.

Ping An Healthcare runs another large online-care platform, and Alibaba Health combines its digital consultation offering with one of China’s largest healthcare e-commerce ecosystems.

Hinge Health leads among telehealth-focused specialists

Under our report’s market-cap-focused methodology, JD Health is the #1 telehealth company.

Only part of JD Health’s revenue comes from its telehealth business, however, so market cap overstates the telehealth footprint of diversified groups like this one.

Within virtual healthcare companies, Hinge Health is the biggest by market value and has focused on a single area of medicine: musculoskeletal care.

With a market cap of $7.15 billion, it ranks above Hims & Hers, Omada Health and Teladoc Health while focusing on that single category.

This valuation gap to Teladoc is illuminating as to what the market is paying for. Teladoc has more than four times the revenue of Hinge Health, and yet Hinge is worth more than six times as much.

Hinge Health in 2025 grew revenue 51% at an 80% gross margin and generated $180 million in free cash flow. This is a clinical program being sold to employers and health plans.

In contrast, Teladoc in 2025 saw revenue decrease by 2% and lost $200 million. The company’s consumer-facing business, BetterHelp, decreased 9% as it transitioned from a subscription model to a per-visit model.

Investors are valuing growth, margin and a defined buyer of a clinical program as opposed to volume of visits.

Elsewhere in the ranking, Doximity trades at 7.1x and Omada at 4.6x, both companies with software economics in their clinical delivery. Amwell and LifeMD, two virtual health service companies, trade at 0.9x and 0.8x respectively, with revenue flat to falling in the service businesses they run.

Consolidation is reducing the number of independent public telehealth companies

Talkspace, which not so long ago would have merited inclusion on this list, went from being a standalone public company to being delisted and acquired by Universal Health Services in August of 2026 for $5.25 per share in cash.

Mental health is the sector where the most action is taking place, and this deal is why: a standalone virtual therapy company was sold to a hospital operator that framed the purchase as connecting virtual care to its inpatient and outpatient facilities.

The model of standalone virtual-only therapy is under pressure on two fronts. On one hand, the cost of consumer acquisition has begun to bite at companies like BetterHelp, with revenue down 9% in 2025. On the other, payers are increasingly keen to contract with providers who can escalate a case to a face-to-face session with a clinician.

Right now the players gaining ground in this sector are hybrids: in 2025 LifeStance added 657 clinicians and posted its first full-year profit as a publicly quoted company.

Kooth, the virtual mental health provider which derives the vast majority of its revenue from government contracts in the UK, saw revenue decline in 2025. Our expectation is that more virtual mental health providers will end up as part of a health system rather than on this list.

Conclusion

The ranking supports three conclusions.

Telehealth is a capability, not a sector

The most basic one is that telehealth has stopped being a sector. It is a capability now, and the market already prices it that way.

Take the $50.2 billion in combined value: $32.1 billion of it, or 64%, belongs to companies where virtual care is one channel inside a pharmacy, clinical or software business. The nine companies built on virtual care alone are worth $18.1 billion between them.

An operator reading this should draw the obvious lesson. Offering telehealth no longer sets anyone apart. It is a distribution choice, and what it is worth depends on what travels through the channel and who is paying for it.

The market prices business models, not size

The second conclusion concerns valuation, and it is more surprising. The market is not rewarding size. It is sorting by business model.

Price-to-sales on this list runs from 0.4x to 12.2x, a thirty-fold gap among companies that supposedly do the same thing. The premium goes to businesses that sell a defined clinical program to an institutional buyer and show the growth and gross margins of software while doing it. Hinge Health and Omada sell to employers and health plans; Doximity sells to physicians.

The discount goes to businesses that sell visits. Teladoc and LifeMD sell them to consumers, Amwell sells them to enterprises, and in each case revenue is flat or shrinking while the provider carries the cost of finding and keeping patients.

The three Chinese platforms fit the same logic from the other direction. They generate 61% of the revenue on this list and trade at 1.2x to 2.1x, because the market sees pharmacy retailers with a consultation layer attached.

Scale buys nothing on its own. Teladoc has the second-largest revenue of the fifteen, $2.53 billion, and the tenth-largest market capitalization.

Health systems are the buyers

The third conclusion is about who is doing the buying. Standalone virtual providers are leaving the public markets through acquisition, and the acquirers are integrated health systems, not other digital health companies.

Universal Health Services taking Talkspace is the clearest signal so far of where virtual mental health ends up: inside provider networks that can combine remote care with their own inpatient and outpatient capacity. LifeStance, which grew its clinician base and posted its first profitable year as a hybrid, points the same way.

The exposed companies are the virtual-only providers paying consumer acquisition costs with no institutional buyer behind them.

What would change this picture

Whether this holds depends on two things. One is Hinge Health. If the premium for employer-sold clinical programs survives a slowdown in its growth, the market is paying for the model; if it does not, the market was paying for momentum.

The other is whether more health systems follow UHS over the next twelve months. If both play out, the 2027 edition of this ranking will have fewer independent telehealth companies on it and more healthcare companies that happen to have a telehealth line.

Methodology & Limitations

We screened public companies that offer some form of telehealth as their main business or a key platform they use to serve their patients and providers.

Companies in the healthcare/digital health space that deliver remote patient care via virtual healthcare and/or technology were considered for this category. This includes “pure-play” telehealth companies as well as larger healthcare companies that generate a substantial amount of revenue from telehealth services to patients and providers.

Companies that are primarily conglomerates, insurance companies or retailers offering telehealth on a relatively small scale were excluded from the list. Companies such as Amazon, CVS Health and UnitedHealth Group offer virtual care but were not included because they are primarily other types of companies with telehealth offered on a relatively small scale.

These companies are listed in descending order by their market capitalization on 11th September 2026 (not their revenue from telehealth sales, number of patients or their share of the market).

Note that companies like JD Health, Alibaba Health, GoodRx and Terveystalo that offer other health services besides telehealth are included in the list, and the market cap quoted is for the whole company, not just the telehealth arm.

Non-U.S. market capitalizations and revenues were converted into U.S. dollars for purposes of comparison using the European Central Bank reference rates as of 11th September 2026.

Note: Market values can fluctuate significantly from day to day, so the figures above reflect the closing market capitalization at the close of business on 11th September 2026.

Note that operating metrics such as number of users or members, number of subscribers, number of consultations or appointments, covered lives and patients (among others) are reported by companies and thus are not likely to be comparable from company to company.

Sanor publishes for general information. This publication is not medical, financial, or investment advice.

Privacy Policy Terms of Service Disclaimer Sitemap

SANOR research follows the principles of ISO 20252:2019 and the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics, and is conducted in line with our Independence Policy. Our published reports follow our Editorial Standards.

SANOR research is funded through advisory engagements and research licensing. We do not accept vendor sponsorship, paid placement, or advertising.

All publications are provided for general information only. They do not constitute medical, financial, or investment advice and do not account for the circumstances of any specific business or individual.